» Articles » PMID: 9663482

Impaired Phagocytosis of Apoptotic Cell Material by Monocyte-derived Macrophages from Patients with Systemic Lupus Erythematosus

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 1998 Jul 15
PMID 9663482
Citations 269
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate whether the established impaired phagocyte function in systemic lupus erythematosus (SLE) patients also affects apoptotic cell clearance. Accumulation of apoptotic waste as a source for autoantigens that induce and maintain autoimmune responses is discussed.

Methods: Apoptosis was detected by morphology and propidium iodide staining. In vitro phagocytosis of autologous apoptotic cells in cultured peripheral blood mononuclear cells was evaluated microscopically. Cross-feeding experiments were performed to investigate phagocytosis of heterologous apoptotic cells by in vitro-differentiated macrophages. Furthermore, the effect of annexin V on the phagocytosis of apoptotic cells was investigated.

Results: Reduced clearance of apoptotic cells in SLE patients was observed. The defective clearance appeared to reflect phagocyte dysfunction and not an abnormal execution of apoptosis. A similar picture was seen when in vitro-differentiated macrophages from control populations were treated with annexin V.

Conclusion: Noninflammatory engulfment phagocytosis of apoptotic cells is decreased in SLE patients. Persistently circulating apoptotic waste may encounter inflammatory removal pathways and serve as immunogen for the induction of autoreactive lymphocytes and as antigen for immune complex formation.

Citing Articles

Role of miRNAs in Apoptosis Pathways of Immune Cells in Systemic Lupus Erythematosus.

Azizan A, Farhadi E, Faezi S, Jamshidi A, Alikhani M, Mahmoudi M Immun Inflamm Dis. 2025; 13(2):e70124.

PMID: 39912562 PMC: 11800236. DOI: 10.1002/iid3.70124.


CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives.

Zhou J, Lei B, Shi F, Luo X, Wu K, Xu Y Front Immunol. 2025; 15:1476859.

PMID: 39749335 PMC: 11694027. DOI: 10.3389/fimmu.2024.1476859.


ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis.

Guillet S, Lazarov T, Jordan N, Boisson B, Tello M, Craddock B Elife. 2024; 13.

PMID: 39570652 PMC: 11581429. DOI: 10.7554/eLife.96085.


Systemic lupus erythematosus: pathogenesis and targeted therapy.

Su X, Yu H, Lei Q, Chen X, Tong Y, Zhang Z Mol Biomed. 2024; 5(1):54.

PMID: 39472388 PMC: 11522254. DOI: 10.1186/s43556-024-00217-8.


In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions.

Atkin-Smith G, Santavanond J, Light A, Rimes J, Samson A, Er J Nat Commun. 2024; 15(1):8802.

PMID: 39438460 PMC: 11496675. DOI: 10.1038/s41467-024-52867-5.